Companies Investors People

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

Contact
Request a Demo
Request Data Updates
Add a Company

Research

Companies
Investors
People

aVenture

Download App
Pricing
Alternatives

Resources

Documentation
Use Cases
CLI
MCP
Sitemap

aVenture is an AI-native agentic deep research tool for researching and finding companies and people, and is a high-quality alternative to AlphaSense, CB Insights, Crunchbase, Dealroom, Harmonic, Owler, Perplexity Finance, PitchBook, Preqin, PrivCo, Synaptic, and Tracxn.

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Insightfil - aVenture Company Research

Insightfil

Insightfil

Insightfil: Revolutionizing patient care by reducing medication errors, optimizing health professional time, and introducing a unique Personalized Wellness Portfolio.

Boston, MA, US🇺🇸

Founded

Insightfil, founded with the mission to revolutionize patient care, focuses on reducing medication errors and improving medication adherence. Their core product, the Personalized Wellness Portfolio (PWP), dispenses custom medication regimens and connects patients, clinics, and pill manufacturers. By optimizing health professional time and eliminating wasted drugs and packaging, Insightfil aims to enhance patient outcomes and streamline the medication administration process.

Notable for its innovative approach, Insightfil has garnered attention from healthcare providers and investors interested in cutting-edge medical technology. The company’s achievements include the successful implementation of NFC-tagged medication convenience packaging, which enhances patient compliance and safety. Insightfil's impact is evident in its ability to reduce costs and risks associated with medication administration, ultimately contributing to better patient care and operational efficiency in healthcare settings.

Insightfil - Similar Companies

PerceptiMed

perceptimed.com

DoseCue

PatchRx

patchrx.io

Insightfil - Quick Facts

Who are Insightfil's competitors?

Companies similar to Insightfil include PerceptiMed, DoseCue, PatchRx and CuePath Innovation.

When was Insightfil founded?

Insightfil was founded in 2014.

Where is Insightfil's headquarters located?

Insightfil's headquarters is located in Boston, MA, US.

When was Insightfil's last funding round?

Insightfil's most recent funding round was for $5.8k (USD) in July 2017.

How much disclosed funding has Insightfil raised?

As of Jul 7, 2017, Insightfil has disclosed funding of $1.8M (USD). Undisclosed round amounts are excluded.

Insightfil - Classification

Industry: Hardware
Ownership: Private
Venture-backed
Technology

How many employees does Insightfil have?

Insightfil has 30 employees as of Feb 4, 2024.

Geographic Exposure

Americas

Revenue: Recurring
Software
Customer: Enterprise
Main Product: Medication Management

Tags: Healthcare
Healthtech
SaaS

NAICS: 620000Health Care and Social Assistance
SIC: 8000Health Services
8040Offices And Clinics Of Other Health Practitioners
8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified

CuePath Innovation

cuepath.io

Wulou Labs

Time Touch Take

timetouchtake.com

Pharmesol

pharmesol.com

PillDrill

pilldrill.com

SmartScripts

smartscripts.com

PillGuard Medication Delivery Systems

PharmID

pharmid.com

PharmAdva

pharmadva.com

Wattson Health

wattsonhealth.com

OneFul Health

oneful.health

InsightRX

insight-rx.com